Efficient retrovirus-mediated cytokine-gene transduction of primary-cultured human glioma cells for tumor vaccination therapy

Japanese Journal of Cancer Research

Volumn 88, Issue 3, 1997, Pages 296-305

  Wakimoto, Hiroaki ^a,b   Yoshida, Yoko ^a   Aoyagi, Masaru ^b   Hirakawa, Kimiyoshi ^b   Hamada, Hirofumi ^a  

^a CANCER CHEMOTHERAPY CENTER   (Japan)

^b TOKYO MEDICAL AND DENTAL UNIVERSITY   (Japan)

Author keywords

Cytokine; Glioma; GM CSF; Retrovirus vector; Tumor vaccine

Indexed keywords

BETA GALACTOSIDASE; CYTOKINE; GENE PRODUCT; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; TUMOR VACCINE;

ARTICLE; CELL CULTURE; CELL PROLIFERATION; CLONING VECTOR; ESCHERICHIA COLI; GENE TRANSFER; GENETIC TRANSDUCTION; GLIOMA CELL; HUMAN; HUMAN CELL; MARKER GENE; PRIORITY JOURNAL; RETROVIRUS; VACCINATION;

EID: 0030997964     PISSN: 09105050     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1349-7006.1997.tb00381.x     Document Type: Article

References (33)

1. Winger, M. J., Macdonald, D. R. and Cairncross, J. G. Supratentorial anaplastic gliomas in adults. J. Neurosurg., 71, 487-493 (1989).
2. Kuppner, M. C., Hamou, M. F. and Tribolet, N. Immunohistological and functional analyses of lymphoid infiltrates in human glioblastomas. Cancer Res., 48, 6926-6932 (1988).
3. Sawamura, Y., Hosokawa, M., Kuppner, M. C., Kobayashi, H., Aida, T., Abe, H. and Tribolet, N. Antitumor activity and surface phenotypes of human glioma-infiltrating lymphocytes after in vitro expansion in the presence of interleukin 2. Cancer Res., 49, 1843-1849 (1989).
4. Fischer, D. K., Chen, T. L. and Narayan, R. K. Immunological and biochemical strategies for the identification of brain tumor-associated antigens. J. Neurosurg., 68, 165-180 (1988).
5. Libermann, T. A., Nusbaum, H. R., Razon, N., Kris, R., Lax, I., Soreq, H., Whittle, N., Waterfield, M. D., Ullrich, A. and Schlessinger, J. H. Amplification, enhanced expression and possible rearrangement of EGFR gene in human brain tumor. Nature, 313, 144-147 (1985).
6. Denlinger, R. H., Axler, D. A., Koestner, A. and Liss, L. Tumor-specific transplantation immunity to intracerebral challenge with cells from a methylnitrosourea-induced brain tumor. J. Med., 6, 249-259 (1975).
7. Kida, Y., Cravioto, H., Hochwald, G. M., Hochgeschwender, U. and Ransohoff, J. Immunity to transplantable nitrosourea-induced neurogenic tumors. J. Neuropathol. Exp. Neurol., 42, 122-135 (1983).
8. Scheinberg, L. C., Suzuki, K., Davidoff, L. M. and Beilin, R. L. Immunization against intracerebral transplantation of a glioma in mice. Nature, 193, 1194-1195 (1962).
9. Scheinberg, L. C., Suzuki, K., Edelman, F. and Davidoff, L. M. Studies in immunization against a transplantable cerebral mouse glioma. J. Neurosurg., 20, 312-317 (1963).
10. Siesjo, P., Visse, E., Lindvall, M., Salford, L. and Sjogren, H. O. Immunization with mutagen-treated (tum-) cells causes rejection of nonimmunogenic rat glioma isografts. Cancer Immunol. Immunother., 37, 67-74 (1993).
11. Bloom, H. J. G., Peckham, M. J., Richardson, A. E., Alexander, P. A. and Payne, P. M. Glioblastoma multiforme: a controlled trial to assess the value of specific active immunotherapy in patients treated by radical surgery and radiotherapy. Br. J. Cancer, 27, 253-267 (1973).
12. Eggers, A. E., Tarmin, L. and Gamboa, E. T. In vivo immunization against autologous glioblastoma-associated antigens. Cancer Immunol. Immunother., 19, 43-45 (1985).
13. Mahaley Jr., M. S., Bigner, D. D., Dudka, L. F., Wilds, P. R., Williams, D. H., Bouldin, T. W., Whitaker, J. N. and Bynum, J. M. Immunobiology of primary intracranial tumors. Part 7: Active immunization of patients with anaplastic human glioma cells: a pilot study. J. Neurosurg., 59, 201-207 (1983).
14. Colombo, M. P. and Forni, G. Cytokine gene transfer in tumor inhibition and tumor therapy: where are we now? Immunol. Today, 15, 48-51 (1994).
15. Pardoll, D. M. Cancer vaccines. Immunol. Today, 14, 310-316 (1993).
16. Berns, A. J. M., Clift, S., Cohen, L. K., Donehower, R. C., Dranoff, G., Hauda, K. M., Jaffee, E. M., Lazenby, A. J., Levitsky, H. I., Marshall, F. F., Mulligan, R. C., Nelson, W. G., Owens Jr., A. H., Pardoll, D. M., Parry, G., Partin, A. H., Piantadosi, S., Simons, J. W. and Zabora, J. R. Phase I study of non-replicating autologous tumor cell injections using cells prepared with or without GM-CSF gene transduction in patients with metastatic renal cell carcinoma. Hum. Gene Ther., 6, 347-368 (1995).
17. Tepper, R. I. and Mule, J. J. Experimental and clinical studies of cytokine gene-modified tumor cells. Hum. Gene Ther., 5, 153-164 (1994).
18. Wakimoto, H., Abe, J., Nakamura, Y., Kanegae, Y., Saito, I., Aoyagi, M., Hirakawa, K. and Hamada, H. Enhanced antitumor effects by cytokine gene-modified tumor vaccines and IL-2-secreting cytotoxic T lymphocytes. In "Gene Therapy," p. 164 (1994). Cold Spring Harbor Laboratory Press, New York.
19. Wakimoto, H., Abe, J., Tsunoda, R., Aoyagi, M., Hirakawa, K. and Hamada, H. Intensified antitumor immunity by a cancer vaccine that produces granulocytemacrophage colony-stimulating factor plus interleukin 4. Cancer Res., 56, 1828-1833 (1996).
20. Dranoff, G., Jaffee, E., Lazenby, A., Golumbek, P., Levitsky, H., Brose, K., Jackson, V., Hamada, H., Pardoll, D. and Mulligan, R. C. Vaccination with irradiated tumor cells engineered to secrete murine granulocyte-macrophage colony-stimulating factor stimulates potent, specific, and long-lasting anti-tumor immunity. Proc. Natl. Acad. Sci. USA, 90, 3539-3543 (1993).
21. Shinnick, T. M., Lerner, R. A. and Sutcliffe, J. G. Nucleotide sequence of Moloney murine leukemia virus. Nature, 293, 543-548 (1981).
22. Alford, R. L., Honda, S., Lawrence, C. B. and Belmont, J. W. RNA secondary structure analysis of the packaging signal for moloney murine leukemia virus. Virology, 183, 611-619 (1991).
23. Bender, M. A., Palmer, T. D., Gelinas, R. E. and Miller, A. D. Evidence that the packaging signal of Moloney murine leukemia virus extends into the gag region. J. Virol., 61, 1639-1646 (1987).
24. Gossen, M. and Bujard, H. Tight control of gene expression in mammalian cells by tetracycline-responsive promoters. Proc. Natl. Acad. Sci. USA, 89, 5547-5551 (1992).
25. Kalderon, D., Roberts, B. L., Richardson, W. D. and Smith, A. E. A short amino acid sequence able to specify nuclear location. Cell, 39, 499-509 (1984).
26. Ghattas, I. R., Sanes, J. R. and Majors, J. E. The encephalomyocarditis virus internal ribosomal entry site allows efficient coexpression of two genes from a recombinant provirus in cultured cells and in embryos. Mol. Cell. Biol. 11, 5848-5859 (1991).
27. Danos, O. and Mulligan, R. C. Safe and efficient generation of recombinant retroviruses with amphotropic and ecotropic host ranges. Proc. Natl. Acad. Sci. USA, 85, 6460-6464 (1988).
28. Pear, W., Nolan, G. P., Scott, M. L. and Baltimore, D. Production of high-titer helper-free retroviruses by transient transfection. Proc. Natl. Acad. Sci. USA, 90, 8392-8396 (1993).
29. Nakamura, Y., Wakimoto, H., Abe, J., Kanegae, Y., Saito, I., Aoyagi, M., Hirakawa, K. and Hamada, H. Adoptive immunotherapy with murine tumor-specific T lymphocytes engineered to secrete interleukin-2. Cancer Res., 54, 5757-5760 (1994).
30. Yamaguchi, S., Wakimoto, H., Yoshida, Y., Kanegae, Y., Saito, I., Aoyagi, M., Hirakawa, K., Amagasa, T. and Hamada, H. Enhancement of retrovirus-mediated gene transduction efficiency by transient overexpression of the amphotropic receptor, GLVR2. Nuclear Acids Res., 23, 2080-2081 (1995).
31. Cepko, C. "Current Protocols in Molecular Biology, 1," pp. 9.11.5-9.11.12 (1993). John Wiley and Sons, New York.
32. Jaffee, E. M., Dranoff, G., Cohen, L. K., Hauda, K. M., Clift, S., Marshall, F. F., Mulligan, R. C. and Pardoll, D. M. High efficiency gene transfer into primary human tumor explants without cell selection. Cancer Res., 53, 2221-2226 (1993).
33. Patel, P. M., Flemming, C.L., Fisher, C., Porter, C. D., Thomas, J. M., Gore, M. E. and Collins, M. K. L. Generation of interleukin-2-secreting melanoma cell populations from resected metastatic tumors. Hum. Gene Ther., 5, 577-584 (1994).